查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1550087

关节内粘稠补充疗法市场:全球产业分析，规模，占有率，成长，趋势，2024-2033年预测

Viscosupplementation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球关节内替代治疗市场的综合报告。该报告对关键市场动态进行了详细评估，包括市场推动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。

主要的洞察

  • 关节内替代疗法市场规模（2024 年）：59 亿美元
  • 预计市值（2033 年）：136 亿美元
  • 全球市场成长率（2024 年至 2033 年复合年增长率）：9.7%

关节内替代治疗市场-报告范围：

关节内替代疗法，即在关节内注射玻尿酸或其他关节内替代疗法，起到润滑和缓解疼痛的作用，常用于治疗骨关节炎。该市场包括多种产品类型，包括单次注射和多次注射的关节内替代治疗，并供应给医院、骨科诊所和专科治疗中心。骨关节炎盛行率的增加、老年人口的增加以及提高治疗效果和患者预后的关节内替代治疗技术的进步推动了市场成长。

市场推动因素：

全球关节内替代治疗市场是由几个关键因素推动的，例如骨关节炎盛行率的增加，这需要有效的管理解决方案。对非手术治疗方案的认识不断提高，以及容易患关节疾病的老年人口不断增加，进一步推动了市场的成长。技术进步，例如改进的关节内替代治疗配方和输送系统的开发，提高了疗效和患者舒适度。此外，关节内替代疗法在其他关节疾病中的应用的扩大以及医疗保健投资的增加正在支持市场的扩张。

市场阻碍因素：

儘管成长潜力巨大，但关节内替代治疗市场面临着治疗成本高且报销范围有限的挑战。关节内替代疗法注射的相关费用可能会成为获得该疗法的障碍，特别是在医疗保健预算有限的地区。此外，对关节内替代疗法的长期安全性和有效性以及可能的副作用的担忧可能会影响市场成长。解决这些问题需要努力提高成本效益并确保全面的安全评估。

市场机会：

由于技术进步、人口变化和不断发展的医疗模式，关节内替代治疗市场提供了巨大的商机。关节内替代治疗产品的创新，例如改进的配方和缓释系统，开闢了新的成长途径。此外，微创手术的日益普及和再生医学的进步为市场参与者提供了广阔的前景。策略联盟、研发投资以及实施具有成本效益的解决方案对于利用新机会和维持市场竞争力至关重要。

本报告涵盖的主要问题

  • 推动全球关节内替代疗法市场成长的关键因素是什么？
  • 哪些类型的关节内替代治疗产品正在各种医疗机构中获得认可？
  • 技术进步如何影响关节内替代治疗市场的竞争格局？
  • 谁是关节内替代治疗市场的主要参与者？ 他们采取什么策略来维持市场地位？
  • 全球关节内替代治疗市场的新趋势和未来前景如何？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 市场风险与趋势的评估

  • 风险评估
    • COVID-19危机和关节内粘稠补充疗法的需求的影响
    • 过去的危机和比较了的COVID-19影响基准
    • 市场金额的影响(10亿美元)
    • 主要国家的评估
    • 主要各市场区隔的评估
    • 与对供应商的行动点推荐事项
  • 影响市场的主要趋势
  • 处方与产品开发趋势

第4章 市场背景和基础数据点

  • 全球关节内粘稠补充疗法市场(10亿美元)
  • 关节内粘稠补充疗法市场机会评估(10亿美元)
    • 整体市场规模
    • 服务可能的整体市场规模
    • 服务可能的可取得的市场
  • 市场情势预测
    • 乐观的情势的需求
    • 预计的情势的需求
    • 保守的情势的需求
  • 投资可行性分析
    • 现有市场的投资
      • 短期性
      • 长期性
    • 新兴市场的投资
      • 短期性
      • 长期性
  • 预测要素- 相关性及影响
    • 龙头企业成长
    • 全球关节内粘稠补充疗法市场成长
    • 地区冷气引进率(各国)
  • 市场动态
    • 市场促进因素及影响评估
    • 主要的市场课题及影响评估
    • 关节内粘稠补充疗法的市场机会
    • 全球市场的显着的趋势与其影响评估

第5章 重要成功要素

  • 厂商渗透率低高成长率市场着重
  • 市场区隔的高(贵)的增量机会赌
  • 同业基准

第6章 全球关节内粘稠补充疗法市场需求分析

  • 过去的市场分析，2019-2023
  • 市场预测，2024～2033年
  • 与前一年同期比较成长趋势分析

第7章 全球关节内粘稠补充疗法市场金额分析

  • 市场金额(10亿美元)分析，2019～2023年
  • 市场金额(10亿美元)预测，2024～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对的商机

第8章 全球关节内粘稠补充疗法市场分析:各产品类型

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，2019～2023年
  • 市场规模(10亿美元)分析与预测，2024～2033年
    • 单回注射
    • 3次的注射
    • 5次的注射
  • 各产品类型的市场魅力分析

第9章 全球关节内粘稠补充疗法市场分析:各终端用户

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，2019～2023年
  • 市场规模(10亿美元)分析与预测，2024～2033年
    • 医院
    • 整形外科诊所/门诊病人手术中心(ASC)
  • 各终端用户市场魅力分析

第10章 全球关节内粘稠补充疗法市场分析:各地区

  • 简介
  • 市场规模(10亿美元)分析，2019～2023年
  • 市场规模(10亿美元)分析与预测，2024～2033年
    • 北美
    • 南美
    • 欧洲
    • 亚太地区
    • 中东及非洲
  • 各地区市场的魅力分析

第11章 北美的关节内粘稠补充疗法市场分析

第12章 南美的关节内粘稠补充疗法市场分析

第13章 欧洲的关节内粘稠补充疗法市场分析

第14章 亚太地区的关节内粘稠补充疗法市场分析

第15章 中东及非洲的关节内粘稠补充疗法市场分析

第16章 主要国家的关节内粘稠补充疗法市场分析

  • 简介
    • 各主要国家的市场金额比较起来分析
    • 与世界各国成长比较
  • 美国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 加拿大的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 墨西哥的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 巴西的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 德国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 法国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 义大利的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 荷比卢三国关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 英国关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 北欧各国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 中国关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 日本的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 韩国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • GCC各国的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 南非的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
  • 土耳其的关节内粘稠补充疗法市场分析
    • 市场各分类价值比率分析
    • 市场各分类的价值与分析及预测，2019-2032年
      • 产品类型
      • 各终端用户
    • 国内的竞争情形和企业的集中度

第17章 市场结构分析

  • 各级企业市场分析
  • 市场集中
  • 主要企业的市场占有率分析
  • 市场影响分析

第18章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详细内容
    • Sanofi
    • Anika Therapeutics, Inc.
    • SEIKAGAKU CORPORATION
    • Zimmer Biomet
    • Smith &Nephew PLC
    • Ferring Pharmaceutical BV
    • Lifecore Biomedical, LLC(Landec)
    • LG Life Sciences Ltd.
    • Fidia Farmaceutici SpA
    • F.Hoffmann-La Roche Ltd.

第19章 所使用的前提条件与缩写

第20章 调查手法

简介目录
Product Code: PMRREP33245

Persistence Market Research has recently released a comprehensive report on the global visco-supplementation market. This report provides an in-depth evaluation of key market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Visco-supplementation Market Size (2024E): USD 5.9 Billion
  • Projected Market Value (2033F): USD 13.6 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 9.7%

Visco-supplementation Market - Report Scope:

Visco-supplementation involves the injection of hyaluronic acid or other viscosupplements into the joints to provide lubrication and relieve pain, commonly used in the treatment of osteoarthritis. The market includes various product types, such as single-injection and multi-injection viscosupplements, and caters to hospitals, orthopedic clinics, and specialized treatment centers. Market growth is driven by the increasing prevalence of osteoarthritis, rising geriatric population, and advancements in viscosupplement technology, enhancing treatment efficacy and patient outcomes.

Market Growth Drivers:

The global visco-supplementation market is driven by several key factors, including the growing incidence of osteoarthritis, which necessitates effective management solutions. The increasing awareness of non-surgical treatment options, coupled with the rising geriatric population prone to joint disorders, further propels market growth. Technological advancements, such as the development of improved viscosupplement formulations and delivery systems, offer enhanced efficacy and patient comfort. Additionally, the expanding application of viscosupplementation in other joint disorders and rising healthcare investments support market expansion.

Market Restraints:

Despite its promising growth potential, the visco-supplementation market faces challenges related to high treatment costs and limited reimbursement coverage. The expense associated with viscosupplement injections can be a barrier to access, particularly in regions with constrained healthcare budgets. Furthermore, concerns regarding the long-term safety and effectiveness of viscosupplementation treatments and the potential for adverse reactions may impact market growth. Addressing these issues requires efforts to improve cost-effectiveness and ensure comprehensive safety assessments.

Market Opportunities:

The visco-supplementation market presents significant opportunities driven by technological advancements, demographic shifts, and evolving healthcare models. Innovations in viscosupplement products, such as enhanced formulations and extended-release systems, create new growth avenues. Additionally, the increasing adoption of minimally invasive procedures and advancements in regenerative medicine offer promising prospects for market players. Strategic collaborations, investment in research and development, and the introduction of cost-effective solutions are crucial to capitalizing on emerging opportunities and maintaining market competitiveness.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the visco-supplementation market globally?
  • Which types of viscosupplement products are gaining traction across various healthcare settings?
  • How are technological advancements influencing the competitive landscape of the visco-supplementation market?
  • Who are the key players in the visco-supplementation market, and what strategies are they employing to sustain market relevance?
  • What are the emerging trends and future prospects in the global visco-supplementation market?

Competitive Intelligence and Business Strategy:

Leading players in the global visco-supplementation market, including Allergan, Anika Therapeutics, and Seikagaku Corporation, focus on innovation, product differentiation, and strategic partnerships to secure a competitive edge. These companies invest in R&D to develop advanced viscosupplement products, such as novel hyaluronic acid formulations and enhanced delivery systems. Collaborations with healthcare providers and distributors facilitate market access and promote technology adoption. Additionally, emphasis on clinical research, evidence-based practice, and patient education supports market growth and improves treatment outcomes in the evolving visco-supplementation landscape.

Key Companies Profiled:

  • Allergan
  • Anika Therapeutics
  • Seikagaku Corporation
  • Revive Therapeutics
  • Mylan N.V.
  • Ferring Pharmaceuticals
  • BioRestorative Therapies
  • OrthogenRx Inc.
  • Celgene Corporation
  • Merz Pharmaceuticals

Market Segments Covered in Viscosupplementation Market Industry Analysis

By Product Type

  • Single Injection
  • Three Injection
  • Five Injection

By End User

  • Hospitals
  • Orthopaedic Clinics/Ambulatory Surgical Centres (ASCs)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
    • 3.1.1. COVID-19 Crisis and Impact on Viscosupplementation Demand
    • 3.1.2. COVID-19 Impact Benchmark with Previous Crisis
    • 3.1.3. Impact on Market Value (US$ Bn)
    • 3.1.4. Assessment by Key Countries
    • 3.1.5. Assessment by Key Market Segments
    • 3.1.6. Action Points and Recommendation for Suppliers
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

  • 4.1. Global Viscosupplementation Market (US$ Bn)
  • 4.2. Viscosupplementation Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Global Viscosupplementation Market Growth
    • 4.5.3. District Cooling Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Viscosupplementation Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Viscosupplementation Market Demand Analysis 2019-2023 and Forecast, 2024-2033

  • 6.1. Historical Market Analysis, 2019-2023
  • 6.2. Current and Future Market Projections, 2024-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Viscosupplementation Market Value Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Product Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2024-2033
    • 8.3.1. Single Injection
    • 8.3.2. Three Injection
    • 8.3.3. Five Injection
  • 8.4. Market Attractiveness Analysis By Product Type

9. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)
  • 9.4. Market Attractiveness Analysis By End User

10. Global Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2024-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
      • 11.4.1.3. Rest of North America
    • 11.4.2. By Product Type
    • 11.4.3. By End User
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Product Type
    • 11.5.3. By End User

12. Latin America Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Rest of Latin America
    • 12.4.2. By Product Type
    • 12.4.3. By End User
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Product Type
    • 12.5.3. By End User

13. Europe Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. France
      • 13.4.1.3. U.K.
      • 13.4.1.4. Italy
      • 13.4.1.5. Benelux
      • 13.4.1.6. Nordic Countries
      • 13.4.1.7. Rest of Europe
    • 13.4.2. By Product Type
    • 13.4.3. By End User
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Product Type
    • 13.5.3. By End User

14. Asia Pacific Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 14.4.1. By Country
      • 14.4.1.1. China
      • 14.4.1.2. Japan
      • 14.4.1.3. South Korea
      • 14.4.1.4. Rest of Asia Pacific
    • 14.4.2. By Product Type
    • 14.4.3. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product Type
    • 14.5.3. By End User

15. Middle East and Africa Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2024-2033
    • 15.4.1. By Country
      • 15.4.1.1. GCC Countries
      • 15.4.1.2. South Africa
      • 15.4.1.3. Turkey
      • 15.4.1.4. Rest of Middle East and Africa
    • 15.4.2. By Product Type
    • 15.4.3. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product Type
    • 15.5.3. By End User

16. Key Countries Viscosupplementation Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
    • 16.1.1. Market Value Proportion Analysis, By Key Countries
    • 16.1.2. Global Vs. Country Growth Comparison
  • 16.2. US Viscosupplementation Market Analysis
    • 16.2.1. Value Proportion Analysis by Market Taxonomy
    • 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By End User
  • 16.3. Canada Viscosupplementation Market Analysis
    • 16.3.1. Value Proportion Analysis by Market Taxonomy
    • 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By End User
  • 16.4. Mexico Viscosupplementation Market Analysis
    • 16.4.1. Value Proportion Analysis by Market Taxonomy
    • 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By End User
  • 16.5. Brazil Viscosupplementation Market Analysis
    • 16.5.1. Value Proportion Analysis by Market Taxonomy
    • 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By End User
  • 16.6. Germany Viscosupplementation Market Analysis
    • 16.6.1. Value Proportion Analysis by Market Taxonomy
    • 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By End User
  • 16.7. France Viscosupplementation Market Analysis
    • 16.7.1. Value Proportion Analysis by Market Taxonomy
    • 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By End User
  • 16.8. Italy Viscosupplementation Market Analysis
    • 16.8.1. Value Proportion Analysis by Market Taxonomy
    • 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By End User
  • 16.9. BENELUX Viscosupplementation Market Analysis
    • 16.9.1. Value Proportion Analysis by Market Taxonomy
    • 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By End User
  • 16.10. UK Viscosupplementation Market Analysis
    • 16.10.1. Value Proportion Analysis by Market Taxonomy
    • 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By End User
  • 16.11. Nordic Countries Viscosupplementation Market Analysis
    • 16.11.1. Value Proportion Analysis by Market Taxonomy
    • 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By End User
  • 16.12. China Viscosupplementation Market Analysis
    • 16.12.1. Value Proportion Analysis by Market Taxonomy
    • 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By End User
  • 16.13. Japan Viscosupplementation Market Analysis
    • 16.13.1. Value Proportion Analysis by Market Taxonomy
    • 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By End User
  • 16.14. South Korea Viscosupplementation Market Analysis
    • 16.14.1. Value Proportion Analysis by Market Taxonomy
    • 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By End User
  • 16.15. GCC Countries Viscosupplementation Market Analysis
    • 16.15.1. Value Proportion Analysis by Market Taxonomy
    • 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By End User
  • 16.16. South Africa Viscosupplementation Market Analysis
    • 16.16.1. Value Proportion Analysis by Market Taxonomy
    • 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By End User
  • 16.17. Turkey Viscosupplementation Market Analysis
    • 16.17.1. Value Proportion Analysis by Market Taxonomy
    • 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2019-2032
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By End User
    • 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies
  • 17.2. Market Concentration
  • 17.3. Market Share Analysis of Top Players
  • 17.4. Market Presence Analysis
    • 17.4.1. By Regional footprint of Players
    • 17.4.2. Product footprint by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Sanofi
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Sales Footprint
      • 18.3.1.4. Strategy Overview
    • 18.3.2. Anika Therapeutics, Inc.
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Sales Footprint
      • 18.3.2.4. Strategy Overview
    • 18.3.3. SEIKAGAKU CORPORATION
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Sales Footprint
      • 18.3.3.4. Strategy Overview
    • 18.3.4. Zimmer Biomet
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Sales Footprint
      • 18.3.4.4. Strategy Overview
    • 18.3.5. Smith & Nephew PLC
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Sales Footprint
      • 18.3.5.4. Strategy Overview
    • 18.3.6. Ferring Pharmaceutical B.V.
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Sales Footprint
      • 18.3.6.4. Strategy Overview
    • 18.3.7. Lifecore Biomedical, LLC (Landec)
      • 18.3.7.1. Overview
      • 18.3.7.2. Product Portfolio
      • 18.3.7.3. Sales Footprint
      • 18.3.7.4. Strategy Overview
    • 18.3.8. LG Life Sciences Ltd.
      • 18.3.8.1. Overview
      • 18.3.8.2. Product Portfolio
      • 18.3.8.3. Sales Footprint
      • 18.3.8.4. Strategy Overview
    • 18.3.9. Fidia Farmaceutici S.p.A
      • 18.3.9.1. Overview
      • 18.3.9.2. Product Portfolio
      • 18.3.9.3. Sales Footprint
      • 18.3.9.4. Strategy Overview
    • 18.3.10. F.Hoffmann-La Roche Ltd.
      • 18.3.10.1. Overview
      • 18.3.10.2. Product Portfolio
      • 18.3.10.3. Sales Footprint
      • 18.3.10.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology